Prednisone Tapering Protocol
Introduction to Tapering
- The optimal prednisone taper depends on the starting dose: for high doses (>30 mg/day), reduce to 10 mg/day within 4-8 weeks, then slow to 1 mg every 4 weeks until discontinuation; for medium doses (10-30 mg/day), reduce by 5 mg weekly to 10 mg/day then switch to the slow taper; for low doses (<10 mg/day), reduce by 1 mg every 4 weeks 1, 2, 3
Critical Timing Principles
- Any patient receiving more than 7.5 mg daily for more than 3 weeks requires tapering to prevent adrenal insufficiency 1, 3
- Divided dosing should only be considered for prominent night pain while on doses below 5 mg daily 1, 2
Dose-Specific Tapering Schedules
- For high initial doses (>30 mg/day), reduce by 5-10 mg weekly until reaching 10 mg/day 1, 2
- For medium initial doses (10-30 mg/day), reduce by 5 mg every 1-2 weeks until reaching 10 mg/day 1, 2
- For low doses (<10 mg/day), reduce by 1 mg every 4 weeks until complete discontinuation 1, 2, 3
Disease-Specific Modifications
- For immune-related adverse events (checkpoint inhibitors), grade 2 events: start 0.5-1 mg/kg/day, taper over 4-6 weeks once symptoms improve to grade ≤1 4, 1, 3
- For polymyalgia rheumatica, initial dose: 12.5-25 mg daily, taper to 10 mg/day within 4-8 weeks 1, 2
- For inflammatory myopathies, initial dose: 0.5-1 mg/kg/day, taper by 10 mg every 2 weeks until reaching 30 mg/day 1
Managing Disease Flare During Tapering
- If symptoms recur at any point, immediately return to the pre-relapse dose and maintain for 4-8 weeks before attempting a slower taper 1, 2, 3
- Consider adding steroid-sparing agents if multiple relapses occur during tapering attempts 1, 3
Stress Dosing Requirements
- During acute illness or physiologic stress while tapering, double the current prednisone dose for 3 days for minor illness 1, 2, 3
- For major stress or surgery, use hydrocortisone 50 mg 2-3 times daily 1, 2
Monitoring Schedule
- Follow-up visits every 4-8 weeks during the first year of tapering 1, 3
- Monitor for three key complications: disease activity markers, signs of adrenal insufficiency, and steroid withdrawal symptoms 1, 3